FDA NDC Directory · JSON-LD · Markdown

Irbesartan and Hydrochlorothiazide

NDC 70518-1550 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerREMEDYREPACK INC.
Marketing categoryAbbreviated NDA (generic) · App ANDA203072
Dosage form / routeTABLET · ORAL
Active ingredientsHYDROCHLOROTHIAZIDE (12.5 mg/1)
IRBESARTAN (300 mg/1)
Marketing started20181018
Package count2

External sources

Source: openFDA. Public-domain (CC0).